Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Metformin in Prevention and Treatment of Cardiac Fibrosis in PAI-1 Deficient Population

NCT05317806 is registered in ClinicalTrials.gov with Indiana Hemophilia &Thrombosis Center, Inc. as lead sponsor.

NCT NCT05317806
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05317806 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Metformin in Prevention and Treatment of Cardiac Fibrosis in PAI-1 Deficient Population
Lead sponsor
Indiana Hemophilia &Thrombosis Center, Inc.
Phase
Phase 4
Overall status
Active, not recruiting
Start date
October 10, 2022
Completion date
October 31, 2027
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac fibrosis, plasminogen activator inhibitor-1 deficiency